{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:03:49Z","timestamp":1789625029495,"version":"build-2803163510"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005227","name":"Jilin Provincial Department of Health","doi-asserted-by":"publisher","award":["JLSRCZX2025-141"],"award-info":[{"award-number":["JLSRCZX2025-141"]}],"id":[{"id":"10.13039\/501100005227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202301ZYTS208"],"award-info":[{"award-number":["YDZJ202301ZYTS208"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>The diagnosis of Fabry disease (FD) in heterozygous females remains clinically challenging, as random X-chromosome inactivation frequently leads to preserved \u03b1-galactosidase A (\u03b1-Gal A) activity and absence of classic clinical stigmata. While concurrent FD and IgA nephropathy (IgAN) is a rare comorbidity predominantly reported in East Asian females, its overlap with systemic autoimmune conditions such as undifferentiated connective tissue disease (UCTD) has not been documented. The shared immunopathogenic mechanisms linking lysosomal sphingolipid storage, immune-mediated glomerular injury, and systemic autoimmunity remain poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns and diagnoses<\/jats:title>\n                    <jats:p>A 44-year-old Chinese woman presented with facial and lower limb edema, proteinuria (2.772 g\/24h), and microscopic hematuria. She lacked classic FD manifestations, and both plasma \u03b1-Gal A activity (4.31 \u03bcmol\/L\/h) and lyso-Gb3 (0.52 ng\/mL) were normal. Renal biopsy confirmed IgAN (Lee grade III, M1E1S1T0-C0) but electron microscopy incidentally identified pathognomonic lamellated zebra bodies in podocytes. GLA gene sequencing identified a heterozygous c.593T&amp;gt;C (p.Ile198Thr) mutation, confirming FD. Serologic workup revealed high-titer ANA (1:1000) and anti-SSA positivity, fulfilling UCTD criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>The patient declined enzyme replacement therapy and received renoprotective regimens combined with hydroxychloroquine. At 6-month follow-up, renal function remained stable and no new UCTD manifestations occurred. Family screening identified her son as a hemizygous GLA carrier.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights that routine electron microscopy during renal biopsy is critical for detecting occult FD in females with normal enzyme activity, and is consistent with a biologically plausible hypothesis of Gb3-driven immune dysregulation as a potential shared link among FD, IgAN, and systemic autoimmunity, which requires further validation in larger cohorts and functional studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1945437","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:32:57Z","timestamp":1789623177000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Concurrent Fabry disease, IgA nephropathy and undifferentiated connective tissue disease in a female with normal enzyme activity"],"prefix":"10.3389","volume":"17","author":[{"given":"Aoteng","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sichao","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Lu","sequence":"additional","affiliation":[{"name":"The First Norman Bethune Clinical College, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2013.02.003","article-title":"Fabry disease peripheral blood immune cells release inflammatory cytokines: Role of globotriaosylceramide","volume":"109","author":"De Francesco","year":"2013","journal-title":"Mol Genet Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0513-2","article-title":"High incidence of autoantibodies in Fabry disease patients","volume":"30","author":"Martinez","year":"2007","journal-title":"J Inher Metab Disea"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfq108","article-title":"Coincidental finding of Fabry's disease in a patient with IgA nephropathy","volume":"3","author":"Kakita","year":"2010","journal-title":"Clin Kidney J"},{"key":"B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-14-6","article-title":"The coincidence of IgA nephropathy and Fabry disease","volume":"14","author":"Maixnerov\u00e1","year":"2013","journal-title":"BMC Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.09.013","article-title":"Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases","volume":"10","author":"Mosca","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/humu.22910","article-title":"Functional and clinical consequences of novel \u03b1-Galactosidase A mutations in Fabry disease","volume":"37","author":"Lukas","year":"2016","journal-title":"Hum Mutat"},{"key":"B9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cca.2018.02.021","article-title":"Functional and pharmacological evaluation of novel GLA variants in Fabry disease identifies six (two de novo) causative mutations and two amenable variants to the chaperone DGJ","volume":"481","author":"Ferri","year":"2018","journal-title":"Clin Chim Acta"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/biomedicines13040767","article-title":"The role of kidney biopsy in Fabry disease","volume":"13","author":"Capelli","year":"2025","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2026.101439","article-title":"A novel entity of renal toxicity after combination chemotherapy: An onco-nephrology kidney biopsy teaching case","volume":"8","author":"Berti","year":"2026","journal-title":"Kidney Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-023-03282-3","article-title":"Concurrent fabry disease and immunoglobulin a nephropathy: a case report","volume":"24","author":"Zhou","year":"2023","journal-title":"BMC Nephrol"},{"key":"B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/8904_2014_371","article-title":"Innate and adaptive immune response in Fabry disease","volume-title":"Jimd Reports, Volume 22","author":"Mauhin","year":"2015"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2019.100454","article-title":"The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts","volume":"19","author":"Germain","year":"2019","journal-title":"Mol Genet Metab Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13546","article-title":"Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients","volume":"96","author":"Germain","year":"2019","journal-title":"Clin Genet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1945437\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:33:00Z","timestamp":1789623180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1945437\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":16,"alternative-id":["10.3389\/fimmu.2026.1945437"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1945437","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1945437"}}